The Indegene date has been confirmed from May 6, 2024 and closes on May 8, 2024. Read the post to learn about Indegene IPO GMP.
Indegene IPO is a fixed price issue of Rs 1,841.76 crores. The price band is set at ₹430 to ₹452 per share. The minimum lot size for an application is 33 Shares. The minimum amount of investment required by retail investors is ₹14,916. The minimum lot size investment for sNII is 14 lots (462 shares), amounting to ₹208,824, and for bNII, it is 68 lots (2,244 shares), amounting to ₹1,014,288.
Start your investing journey today. Find the latest information on Upcoming IPOs.
Key Details Of Indegene IPO
Bidding Dates
May 6-8
Price Range
₹430 to ₹452 per share
Face Value
₹2 per share
GMP
₹290
Indegene IPO GMP
The Indegene IPO GMP is ₹290.
IPO Overview
The Indegene IPO is a book-built issue for Rs 1,841.76 crore. The offering consists of a fresh issue of 1.68 crore shares for Rs 760.00 crores and an offer for sale of 2.39 crore shares for Rs 1,081.76 crores. Indegene’s initial public offering (IPO) begins on May 6, 2024 and ends on May 8, 2024. The allotment for the IPO is expected to be completed on Thursday, May 9, 2024. The Indegene IPO will list on the BSE and NSE, with a tentative listing date of Monday, May 13, 2024.
The IPO pricing range is established at ₹430 to ₹452 per share. The minimum lot size for an application is 33 shares. Retail investors are needed to invest a minimum of ₹14,916. The minimum lot size investment for sNII is 14 lots (462 shares) worth ₹208,824, while for bNII, it is 68 lots (2,244 shares) for ₹1,014,288.
Indegene IPO Details
| IPO Date | May 6, 2024 to May 8, 2024 |
| Listing Date | [.] |
| Face Value | ₹2 per share |
| Price Band | ₹430 to ₹452 per share |
| Lot Size | 33 Shares |
| Total Issue Size | 40,746,891 shares (aggregating up to ₹1,841.76 Cr) |
| Fresh Issue | 16,814,159 shares (aggregating up to ₹760.00 Cr) |
| Offer for Sale | 23,932,732 shares of ₹2 (aggregating up to ₹1,081.76 Cr) |
| Employee Discount | Rs 30 per share |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 222,435,091 |
| Share holding post issue | 239,249,250 |
Indegene Limited Financial Information
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 2,518.15 | 2,203.87 | 1,353.47 | 596.04 |
| Revenue | 1,969.75 | 2,364.10 | 1,690.50 | 996.92 |
| Profit After Tax | 241.90 | 266.10 | 162.82 | 149.41 |
| Net Worth | 1,327.00 | 1,063.72 | 763.90 | 324.51 |
| Reserves and Surplus | 1,282.65 | 1,019.43 | 763.55 | 324.19 |
| Total Borrowing | 399.33 | 394.34 | 18.24 | 24.76 |
| Amount in ₹ Crore | ||||
Indegene IPO Timeline
| IPO Open Date | Monday, May 6, 2024 |
| IPO Close Date | Wednesday, May 8, 2024 |
| Basis of Allotment | Thursday, May 9, 2024 |
| Initiation of Refunds | Friday, May 10, 2024 |
| Credit of Shares to Demat | Friday, May 10, 2024 |
| Listing Date | Monday, May 13, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on May 8, 2024 |
Company Profile
Indegene Limited, established in 1998, provides digital services to the life sciences industry. They help with drug development, clinical trials, regulatory filings, pharmacovigilance, complaint resolution, and sales/marketing support. DT Associates Limited, a subsidiary of the corporation, offers consulting services under the “DT Consulting” name. It assists life sciences organisations in managing their digital transformation activities to ensure ongoing success in customer experience. The organisation got the Platinum Level award at the 2023 Healthy Workplace Conference
and Awards, which was organised by Arogya World India Trust in collaboration with the Public Health Foundation of India. As of December 31, 2023, the company had 65 clients actively using its services. As of December 31, 2023, the corporation had 5,181 employees worldwide. Of them, 4,461 are based in India, 530 in North America, 105 in Europe, 73 in China, and 12 elsewhere.
The company’s services can be divided into following categories
- Enterprise Commercial Solutions
- Omnichannel Activation
- Enterprise Medical Solutions
- Enterprise Clinical Solutions and consultancy services
Registrar Info
| Name | Link Intime India Private Ltd |
| Phone number | +91-22-4918 6270 |
| Email ID | [email protected] |
| Website | linkintime.co.in |
Contact Details
| Name | Indegene Limited |
| Phone number | +91 80 4674 4567 |
| Email ID | [email protected] |
| Website | indegene.com |
IPO Strenghts
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.
Indegene IPO FAQs
When Indegene IPO will open?
The Indegene IPO opens on May 6, 2024 and closes on May 8, 2024.
What is the lot size of Indegene IPO?
Indegene IPO lot size is 33 Shares, and the minimum amount required is ₹14,916.
When is Indegene IPO allotment?
The finalization of Basis of Allotment for Indegene IPO will be done on Thursday, May 9, 2024, and the allotted shares will be credited to your demat account by Friday, May 10, 2024.
When is Indegene IPO listing date?
The Indegene IPO listing date is not yet announced. The tentative date of Indegene IPO listing is Monday, May 13, 2024.
